Characterisation of patients with chronic obstructive pulmonary disease initiating single-device inhaled corticosteroids/long-acting β(2)-agonist dual therapy in a primary care setting in England

Author

Keywords

Administration, Inhalation

Adrenal Cortex Hormones

Adrenergic beta-2 Receptor Agonists/adverse effects

*Asthma/drug therapy

Beclomethasone/therapeutic use

Budesonide, Formoterol Fumarate Drug Combination/therapeutic use

Formoterol Fumarate/therapeutic use

Muscarinic Antagonists/therapeutic use

Primary health care

*Pulmonary Disease, Chronic Obstructive/drug therapy

Retrospective Studies

COPD epidemiology

COPD pharmacology

inhaler devices

Year of Publication

2022

Journal

BMJ Open Respir Res

Volume

9

ISBN Number

2052-4439

Accession Number

36171051

DOI

10.1136/bmjresp-2022-001243